[144] Aurora Innovation, Inc. SEC Filing

Rhea-AI Filing Summary

Aurora Innovation, Inc. (AUR) filed a Form 144 notice disclosing a proposed sale of 50,000 common shares that vested as restricted stock under a registered plan on 05/21/2025. The securities are held for compensation purposes and the filer lists Morgan Stanley Smith Barney LLC as the broker. The approximate sale date is 09/30/2025 on NASDAQ, and the aggregate market value of the shares at the time of the notice is shown as $269,675.00. Total shares outstanding are reported as 1,506,035,025. The filer indicates no securities sold in the past three months and affirms no undisclosed material adverse information.

Positive

• Full disclosure of the intended sale including acquisition date, nature (restricted stock vesting), broker, and aggregate market value
• No reported sales in the prior three months, noted in the filing

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider disclosure of vested restricted shares to be sold; transaction size is small relative to outstanding shares.

The filing records a planned sale of 50,000 common shares acquired via restricted stock vesting on 05/21/2025, with an approximate sale date of 09/30/2025. The broker is Morgan Stanley Smith Barney LLC and the market value reported is $269,675. The filing states no sales in the prior three months and includes the required attestation about material nonpublic information. This is a standard Rule 144 notice documenting an insider's intended disposition for compliance and public transparency.

Corporate Governance Expert

TL;DR: Compliance-focused filing documenting compensation-related share vesting and intended sale under Rule 144.

The notice details shares issued as compensation that vested and are intended for sale via a registered broker on NASDAQ. The filer certifies lack of undisclosed material adverse information, and no prior three-month sales are reported. From a governance standpoint, the filing fulfills disclosure obligations tied to insiders disposing of compensation equity and helps maintain market transparency.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	269675.00	1506035025	09/30/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/21/2025	Restricted stock vesting under a registered plan	Issuer			50000	05/21/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Aurora (AUR) disclose in this Form 144?

The filing discloses a proposed sale of 50,000 common shares that vested as restricted stock on 05/21/2025, with an approximate sale date of 09/30/2025 on NASDAQ.

Who is the broker handling the proposed sale for AUR?

The broker listed is Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, 8th Floor, New York, NY.

What is the aggregate market value and number of shares outstanding reported?

The aggregate market value is reported as $269,675.00 for the 50,000 shares; total shares outstanding are listed as 1,506,035,025.

When were the securities acquired and what was the nature of acquisition?

The securities were acquired on 05/21/2025 through restricted stock vesting under a registered plan and payment is noted as compensation.

Did the filer report any securities sold in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.